New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
05:55 EDTAVEO, AVEO, CAH, CAH, ABC, ABC, AET, AET, CVS, CVS, BMY, BMY, JPM, JPM, MCK, MCK, CLSN, CLSNCBI to host a forum
6th Annual Forum on Oncology Market Access & Payer Strategies is being held in Philadelphia on January 30-31.
News For MCK;CLSN;AVEO;CAH;ABC;AET;CVS;BMY;JPM From The Last 14 Days
Check below for free stories on MCK;CLSN;AVEO;CAH;ABC;AET;CVS;BMY;JPM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 11, 2014
07:04 EDTJPMJPMorgan board authorizes firm to repurchase $6.5B of common equity
The board authorized the firm to repurchase $6.5B of common equity commencing within Q2 this year through the end of the first quarter of 2015. During the first quarter of 2014, the Firm repurchased $400M of common equity. The Federal Reserve Board informed the Firm that it does not object to the Firm’s proposed 2014 capital distribution plan.
07:03 EDTJPMJPMorgan reports Q1 Consumer and Community Banking revenue $10.46B
Subscribe for More Information
07:03 EDTJPMJPMorgan board increases quarterly dividend to 40c from 38c
Subscribe for More Information
07:01 EDTJPMJPMorgan reports Q1 Basel 1 Tier 1 Capital Ratio 12.1%
Subscribe for More Information
07:01 EDTJPMJPMorgan reports Q1 EPS $1.28, consensus $1.40
Subscribe for More Information
07:00 EDTJPMJPMorgan reports Q1 EPS $1.28, consensus $1.40
Reports Q1 revenue $22.99B, consensus $24.53B
06:03 EDTJPMJPMorgan CEO Jamie Dimon hopes to minimize corporate cash, WSJ says
Subscribe for More Information
April 10, 2014
15:25 EDTJPMNotable companies reporting before tomorrow's open
Subscribe for More Information
13:33 EDTJPMEarnings Preview: Analysts mixed on JPMorgan into Q1 results
Subscribe for More Information
13:08 EDTJPMJP Morgan April weekly 58 straddle priced for 2% move into Q1
Subscribe for More Information
11:23 EDTCVSRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
10:00 EDTABCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:55 EDTABCAmerisourceBergen upgraded at ISI Group
Subscribe for More Information
08:37 EDTJPMDimon admits JPMorgan had 'tin ear' when listening to regulators, Reuters says
JPMorgan CEO Jamie Dimon said the company had a “tin ear” when dealing with regulators before settling investigations into mortgage lapses and trading losses, according to Reuters, citing comments from Dimon in a letter to the bank's investors. Dimon said, "Our response generally was, ‘We know what we’re doing.' Well, we should have done more self-examination. We need to be better listeners.” Reference Link
07:43 EDTJPMJPMorgan (JPM) CEO says 2013 was a year of 'pain,' WSJ reports
J.P. Morgan CEO Jamie Dimon acknowledged in his annual shareholder letter that legal issues and new regulations faced by the bank made 2013 "the most painful, difficult and nerve-wracking experience" he has ever dealt with professionally, reported The Wall Street Journal. Reference Link
07:04 EDTBMYBristol-Myers presents Phase III data on all-oral Daclatasvir and Asunaprevir
Subscribe for More Information
06:41 EDTJPMGo Daddy hires Morgan Stanley, JPMorgan for IPO, NY Times says
Subscribe for More Information
06:38 EDTABCAmerisourceBergen upgraded to Buy from Neutral at ISI Group
Subscribe for More Information
06:36 EDTAVEOAveo Pharmaceuticals and Biodesix to co-develop Ficlatuzumab
Subscribe for More Information
06:35 EDTJPMMobile banking presents opportunity and risks for banks, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use